Bambusa Therapeutics believes the I&I field is long overdue for innovative approaches and transformative therapeutics. Since our inception, we have built a diverse portfolio of molecules and are uniquely positioned to make significant contributions to patients suffering from debilitating and chronic inflammatory conditions.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 22 Boston Wharf Rd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.bambusatx.com/
- HQ
- BOSTON, MA
Bambusa Therapeutics Questions
Bambusa Therapeutics's website is https://www.bambusatx.com/
Bambusa Therapeutics's LinkedIn profile is https://www.linkedin.com/company/bambusatherapeutics
Bambusa Therapeutics has
7 employees.
View email and phone details for 7
employees at Bambusa Therapeutics.
Bambusa Therapeutics's industry is
Biotechnology Research
Bambusa Therapeutics's top competitors are
Oncoc4, Inc.,
Otsuka Pharmaceutical Companies (U.s.),
Nocti,
Syncromune®,
Bambusa,
Neurosterix,
Zivo Bioscience, Inc.,
Draig Therapeutics,
Ansun Biopharma, Inc.,
Tellus Therapeutics, Inc.
Bambusa Therapeutics's categories are Biotechnology Research
Bambusa Therapeutics's founding year is 2024
